QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
EQS-News: QUANTRO Therapeutics GmbH / Key word(s): Miscellaneous QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class
EQS-News: QUANTRO Therapeutics GmbH / Key word(s): MiscellaneousQUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments 04.06.2024 / 23:07 CET/CESTThe issuer is solely responsible for the content of this announcement.QUANTRO Therapeutics rea.
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, April 12, 2023 ONWARD Medical N.V. , the medical technology company creating innovative therapies to restore movement,. | April 12, 2023
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, April 12, 2023 (GLOBE NEWSWIRE) ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies